Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 15  •  09:30AM ET
27.89
Dollar change
-0.15
Percentage change
-0.52
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings36 Perf Week-3.93%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM66.07M Perf Month5.87%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter22.51%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High29.30 -4.81% Perf Half Y15.67%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 48.51% Perf YTD19.24%
Active/Passive Quant Type Tagsmedical Flows% 1M2.17% Volatility0.85% 1.22% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M4.97% ATR (14)0.42 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD11.65% RSI (14)55.11 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.54% Growth/Value SMA20-0.42% Flows% 3Y Rel Volume0.00 Prev Close28.04
Inverse/Leveraged Market Cap SMA506.56% Flows% 5Y Avg Volume3.32K Price27.89
IPOOct 31, 2024 Option/ShortNo / Yes SMA20013.66% Trades Volume2 Change-0.52%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.